Nucleus Genomics, a genetic trial company founded by a 25 -year -old Sadigi entity, It was initially launched in 2021 In order to calculate the patient’s risk of specific diseases.
But it was leaving the controversy for years with products that claim to tell people how genetics are related to a set of complex issues, including intelligence rate.
On Wednesday, I raised the controversy to the level of ear division when it announced a new product called Nucleus Merryo With a tweet However, “every father wants to give their children more than it was. For the first time in human history, the nucleus adds a new tool to this commitment.”
Nucleus says it can test artificial insemination embryos not only for known known genes that have a great opportunity for diseases such as breast cancer, but also for appearance-sex, length, hair color, eye color-as well as intelligence and complex health features such as anxiety and ADHD.
The release video includes a screenshot of the comparison menu. The idea is to help parents choose the embryos that must be selected and ignored.
The genetic test of the fetus was not heard of it. Artificial insemination doctors You can test for Genes that can cause conditions such as Down syndrome, or when parents know that they are of great danger to a specific genetic disorder, such as cystic fibrosis.
But this is not exactly what the nucleus is doing. It uses controversial “multi -genetic degrees” to determine “complex genetic results, such as intelligence and anxiety,” says a spokesman.
According to the National Institute of Human Genome Research, multi -genetic degrees only calculate the possibilities of a specific complex disease, especially within the population. “The degree of multi -genetic risk can only be explained by the relative risk of the disease,” NHGR says. This is not the same discovery of a specific gene, for example the BRCA1 genes mutation, which gives a person 60-80 % “absolute risk of breast cancer”, ” NHGR says.
There is a reason that doctors usually do not use such tests for individuals. “Multi -genetic risk degrees have not been used routinely by health professionals because there are no guidelines for practice and researchers still improve how to generate these degrees,” According to NHGR.
Nucleus stamps that its method can be used to determine the risk of an individual. We pointed out a spokesman for Paper 2018 The authors said that they have developed methods that were validated for five common diseases: coronary artery disease, atrial fibrillation, type 2 diabetes, inflammatory bowel disease, and breast cancer.
This paper was defending offers to help individuals take life or therapeutic decisions, similar to the concept of the first nucleus.
On Wednesday, the promising parents tweet was that a nucleus could help them create designer children. It has now been seen more than 4 million times and has hundreds of comments, and many of them either express the lack of ratification that this works as he promised, or terror in the idea.
one VC harmoniously In the discussion, “I was going to write something like Noah, get the boat but frankly this makes me very nauseous.”
The nucleus of this type of controversy has seen before TECHRUNCH previously reportedWhen it announced the series A.M. Million dollars earlier this year. The startup is supported by the Founders Fund, Alexis Ohanian 776, And angels, including Adrien Aoun (FORWARD Health CEO), Brent Sonders (former CEO of Allergan), and Matteo Franceschetti (CEO of Eight Sleep).
Last year, Sadeghi Nucleus IQ, which is supposed to tell users about the impact of genetics on intelligence. The product was detonated As “bad sciences and major business” By some critics. Sadeghi Publish a long defense His company methodology.
However, informing adults that they are intelligent geneticists is one thing. Telling parents that they can choose the appearance and other complex features of their children is, Many argueAnother thing.
nucleus Do not currently take such tests through artificial insemination laboratory partners Helf, Wall Street Journal reports. It is a partnership with genetic prediction, which works with artificial insemination clinics. An executive official told the Genome to the WSG newspaper that many parents are asking for intelligence tests, and not providing that. Parents can voluntarily download genetic data information to the nucleus if they want to follow it.
Or, as Sadeghi said in the video aimed at potential parents: “Not long ago IV-1 raised fear and stigma test tube test,” he said. “What was controversial is now a daily practice. The same applies with genetic improvement. Technology is now here and it is here to stay.”
https://techcrunch.com/wp-content/uploads/2025/06/Nucleus-Genomics-Kian-Sadeghi.png?resize=1200,671
Source link